SpaceX IPO is the biggest IPO in stock market history. Join the conversation.Click here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksOxford Instruments Regulatory News (OXIG)

Share Price Information for Oxford Instruments (OXIG)

Share Price is delayed by 15 minutes
Get Live Data
2,878.00    130.00 (4.73%)
Bid:
2,846.00
Ask:
2,862.00
Spread: 16.00 (0.562%)
Market Cap: £1.59b
OXIG Live PriceLast checked at - London Stock Exchange

Intraday Oxford Instruments Share Chart

Trading Update

26 Mar 2021 07:00

RNS Number : 5574T
Oxford Instruments PLC
26 March 2021
 

 

Oxford Instruments plc

Trading Update 26 March 2021

 

Oxford Instruments plc, a leading provider of high technology products and services to industrial companies and scientific research communities, is today issuing a trading update.

 

The Group has made good progress in the second half of the financial year, maintaining its good order growth, particularly across Asia, which benefited from a continued strong performance from China. Our end markets have remained resilient, with the strongest growth across semi-conductor applications.

 

Revenue is expected to be marginally ahead of last year, including a small adverse impact from currency effects. We expect Adjusted operating profit for the 2020/21 financial year to be between £55m to £57m, supported by realised operating efficiencies.

 

 

Oxford Instruments' results for the year ended 31 March 2021 will be released on 8 June 2021.

 

Note: Adjusted operating profit is before amortisation of acquired intangible assets, fair value movements on financial derivatives and acquisition items.

This announcement contains inside information. The person responsible for arranging the release of this announcement on behalf of Oxford Instruments is Gavin Hill, Group Finance Director.

 

 

 

Enquiries:

 

Oxford Instruments plc Tel: 01865 393200

Ian Barkshire, Chief Executive

Gavin Hill, Group Finance Director

 

MHP Communications Tel: 020 3128 8572

Katie Hunt/ James Midmer/ Florence Mayo

oxfordinstruments@mhpc.com 

 

 

- Ends -

Issued for and on behalf of Oxford Instruments plc

 

 

 

 

 

 

Notes to Editors  

 

About Oxford Instruments plc

 

Oxford Instruments designs, supplies and supports high-technology tools and systems with a focus on research and industrial applications. Innovation has been the driving force behind Oxford Instruments' growth and success for 60 years, supporting its core purpose to address some of the world's most pressing challenges. 

 

The first technology business to be spun out from Oxford University, Oxford Instruments is now a global company and is listed on the FTSE250 index of the London Stock Exchange (OXIG). Its strategy focuses on being a customer-centric, market-focused Group, understanding the technical and commercial challenges faced by its customers. Key market segments include Semiconductor & Communications, Advanced Materials, Healthcare & Life Science, and Quantum Technology.

 

Their portfolio includes a range of core technologies in areas such as low temperature and high magnetic field environments; Nuclear Magnetic Resonance; X-ray, electron, laser and optical based metrology; atomic force microscopy; optical imaging; and advanced growth, deposition and etching.

 

Oxford Instruments is helping enable a greener economy, increased connectivity, improved health and leaps in scientific understanding. Their advanced products and services allow the world's leading industrial companies and scientific research communities to image, analyse and manipulate materials down to the atomic and molecular level, helping to accelerate R&D, increase manufacturing productivity and make ground-breaking discoveries.

 

 

 

 

 

 

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTSEWFWIEFSEFD
Date   Source Headline
12th Jun 20269:25 amPRNTransaction in Own Shares
9th Jun 20267:00 amRNSPreliminary Results
1st Jun 20262:03 pmPRNTotal Voting Rights
1st Jun 20261:59 pmPRNIssue of Equity
27th May 20261:58 pmPRNHolding(s) in Company
22nd May 20268:30 amPRNTransaction in Own Shares
14th May 202610:15 amPRNIssue of Equity
8th May 20268:36 amPRNTransaction in Own Shares
1st May 20269:05 amPRNTotal Voting Rights
1st May 20269:00 amPRNTransaction in Own Shares
24th Apr 20268:32 amPRNTransaction in Own Shares
17th Apr 20268:48 amPRNTransaction in Own Shares
14th Apr 202611:07 amPRNHolding(s) in Company
14th Apr 20267:00 amRNSTrading Update
13th Apr 20262:10 pmPRNHolding(s) in Company
13th Apr 20269:15 amPRNHolding(s) in Company
10th Apr 20267:00 amPRNTransaction in Own Shares
7th Apr 202611:11 amPRNTransaction in Own Shares
1st Apr 20263:26 pmPRNHolding(s) in Company
1st Apr 20262:19 pmPRNTotal Voting Rights
30th Mar 20262:54 pmPRNHolding(s) in Company
27th Mar 20268:31 amPRNTransaction in Own Shares
25th Mar 20263:15 pmPRNHolding(s) in Company
20th Mar 20269:00 amPRNTransaction in Own Shares
20th Mar 20268:00 amPRNHolding(s) in Company
17th Mar 202610:00 amPRNHolding(s) in Company
13th Mar 20267:00 amRNSTransaction in Own Shares
13th Mar 20267:00 amPRNTransaction in Own Shares
5th Mar 20262:40 pmPRNHolding(s) in Company
5th Mar 20267:00 amPRNTransaction in Own Shares
4th Mar 20267:00 amPRNTransaction in Own Shares
3rd Mar 20267:00 amPRNTransaction in Own Shares
2nd Mar 202610:38 amPRNTotal Voting Rights
2nd Mar 20267:00 amPRNExtension of Share Buyback Programme
27th Feb 20267:00 amPRNTransaction in Own Shares
26th Feb 20267:00 amPRNTransaction in Own Shares
25th Feb 20267:00 amPRNTransaction in Own Shares
24th Feb 20267:00 amPRNTransaction in Own Shares
23rd Feb 20267:00 amPRNTransaction in Own Shares
20th Feb 20267:00 amPRNTransaction in Own Shares
19th Feb 20267:00 amPRNTransaction in Own Shares
18th Feb 20267:00 amPRNTransaction in Own Shares
17th Feb 20267:00 amPRNTransaction in Own Shares
16th Feb 20267:00 amPRNTransaction in Own Shares
13th Feb 20267:00 amPRNTransaction in Own Shares
12th Feb 20267:00 amPRNTransaction in Own Shares
10th Feb 20267:00 amPRNTransaction in Own Shares
9th Feb 20267:00 amPRNTransaction in Own Shares
6th Feb 20267:00 amPRNTransaction in Own Shares
5th Feb 20267:00 amPRNTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.